BPH videos on TikTok and Bilibili leave major clinical gaps
Patients searching for benign prostatic hyperplasia information online are entering a crowded, uneven field where reach and reliability do not travel together. In a cross-sectional analysis of Chinese short-video content, investigators compared TikTok and Bilibili to see how well each platform serves people trying to understand symptoms, risk, evaluation, and treatment decisions. The answer was mixed: the videos were accessible and often popular, but clinically incomplete in ways that matter at the bedside and in the consultation room.
The study retrieved the top 100 videos from each platform on March 12, 2026 using the Chinese keyword for BPH, then removed unrelated and duplicate items before analyzing 171 videos in total: 98 from TikTok and 73 from Bilibili. Two urologists independently scored reliability with modified DISCERN, educational quality with the Global Quality Score, and content coverage with a study-specific completeness measure spanning definition, symptoms, risk factors, evaluation, management, and outcomes. Agreement between raters was excellent across domains, with Cohen’s κ above 0.80, giving the content review a strong methodological footing.
One result stood out immediately. TikTok was dominated by professional creators, while Bilibili included a much larger share of institutional and non-professional institutional accounts, and the difference was statistically significant.
Creator type shaped length, completeness, and the tone of information
Creator composition was not a cosmetic detail. On TikTok, professional individuals accounted for 96.9% of videos, whereas professional and non-professional institutions together made up 32.8% of Bilibili content. TikTok videos were also shorter, with a median duration of 62 seconds versus 116 seconds on Bilibili, yet they attracted higher engagement overall. Shorter clips are easier to consume, but brevity can compress clinical context to the point where nuance disappears, especially for a condition like BPH where symptom burden, exclusion of other diagnoses, and treatment choice depend on a sequence of questions rather than a single visual hook.
Despite these platform differences, the overall clinical quality profiles were closer than many clinicians might expect. Median completeness scores and Global Quality Scores were similar across the two platforms, suggesting that neither environment reliably outperformed the other on educational depth. TikTok did show a slightly higher median modified DISCERN score, 3 versus 2, which points to somewhat better structural reliability. Even so, both platforms fell short of providing the full clinical picture a patient would need before making decisions about self-care, medication, or referral.
Risk factors and evaluation were the weakest links
The most consequential finding was not what the videos included, but what they left out. Risk factors and evaluation were the least covered domains across the sample. Those omissions matter because BPH does not exist in isolation; urinary symptoms can overlap with infection, bladder dysfunction, neurologic disease, medication effects, and malignancy, and the workup often determines whether conservative management is appropriate or whether a patient needs a fuller urologic assessment.
When digital videos skip risk stratification and evaluation, they invite a misleadingly simple narrative: identify urinary symptoms, name the condition, and move straight to treatment. Real-world care is rarely that linear. Men with progressive lower urinary tract symptoms may need a careful history, symptom scoring, assessment of complications, and targeted discussion of when observation is reasonable versus when intervention is warranted. A video that stops at symptom recognition may inform, but it does not equip a patient for a decision.
Institutional videos were longer and scored better on both completeness and educational quality, although those subgroups were small. The pattern suggests that institutions may be better positioned to produce balanced content, especially when they have the time and editorial resources to cover both symptom relief and clinical triage. Longer videos can accommodate basic pathophysiology, red flags, and treatment trade-offs without collapsing everything into a slogan-sized explanation.
Engagement did not reliably track educational value
High view counts did not mean high-quality education. On TikTok, view count remained weakly associated with lower completeness after adjustment for duration and uploader type, with a partial rs of -0.21 and a p value of 0.032. No comparable association appeared on Bilibili. In practical terms, popularity on one platform may reward pacing, style, or algorithmic momentum more than medical substance. A video can circulate widely while still omitting the very details that help a patient decide whether to seek care.
For clinicians, this matters because patients increasingly arrive with information filtered through short-form video logic: rapid, emotionally legible, and often incomplete. The format favors clarity, but not necessarily accuracy. If a patient has seen several clips about nocturia, weak stream, or frequent urination, the next question in clinic is not whether they have heard of BPH. It is whether they have heard enough to understand risk factors, evaluation, and the limits of self-diagnosis.
What the findings mean for digital urology education
This cross-sectional sample does not prove how platform algorithms shape exposure, and it does not measure patient outcomes. Even so, it reveals a consistent educational flaw in contemporary BPH content: the most visible material is not reliably the most clinically useful. The study points to practical targets for clinician-led and institution-led digital education in China, especially around risk factors and diagnostic evaluation, where the content deficit was most pronounced.
The result is less a verdict on short-video medicine than a reminder of what short video cannot easily carry. BPH education needs enough space to explain who should be reassured, who should be evaluated further, and why symptom relief alone is not the same as disease assessment. Platforms can amplify awareness, but they do not automatically deliver clinical completeness. In this dataset, the gap between attention and utility remained wide, and that gap is where patients are most likely to misread the seriousness of their symptoms or the next step in care.